Clinical Trial Update: REduCed Dose of TNFi in Patients With Ankylosing SpondyliTis (RECAST) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating a reduced dose of a TNF inhibitor in patients with ankylosing spondylitis and axial spondyloarthritis; status is currently u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Axial Spondyloarthritis

Snippet

Sponsor: Hanyang University Seoul Hospital | Conditions: Ankylosing Spondylitis, Axial Spondyloarthritis | Phase 4 | Status: UNKNOWN